Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04534504
Other study ID # SG-uncut JJB 01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 26, 2020
Est. completion date August 31, 2022

Study information

Verified date August 2020
Source Beijing Chao Yang Hospital
Contact Jia Gang Han
Phone 86-10-85231604
Email hanjiagang@ccmu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Among various bariatric procedures, sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the most frequently performed procedures worldwide. Though SG provides similar weight loss effect to RYGB in short-term follow-up, its long-term and very long-term weight loss effect was reported to be inferior to RYGB. Weight regain after SG remains the major concern after 2-year follow-up due to gradual loss of appetite suppression and lack of malabsorption function. SG plus procedures have been developed to strengthen the effect of SG on diabetes control. It has been reported that SG plus jejunojejunal bypass (SG - JJB) offered better weight loss than SG and similar weight loss to RYGB. The present study aims to evaluate the efficacy and safety of sleeve gastrectomy plus uncut jejunojejunal bypass (SG - uncut JJB).


Description:

Among various bariatric procedures, sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the most frequently performed procedures worldwide. Though SG provides similar weight loss effect to RYGB in short-term follow-up, its long-term and very long-term weight loss effect was reported to be inferior to RYGB. Weight regain after SG remains the major concern after 2-year follow-up due to gradual loss of appetite suppression and lack of malabsorption function. SG plus procedures have been developed to strengthen the effect of SG on diabetes control. It has been reported that SG plus jejunojejunal bypass (SG - JJB) offered better weight loss than SG and similar weight loss to RYGB. The present study aims to evaluate the efficacy and safety of sleeve gastrectomy plus uncut jejunojejunal bypass (SG - uncut JJB).

For SG-JJB procedure, after SG was finished, the jejunum was transected 20-cm distal to Treiz ligament. After that, another 200-cm jejunum was measured and side-to-side jejunojejunal anastomosis was made. The anastomotic and mesenteric defects were closed by hand suture.

For SG-uncut JJB procedure, the jejunum was not transected, only 200-cm jejunum 20-cm distal to Treiz ligament was measured and side-to-side jejunojejunal anastomosis was made. And the jejunum 3-5cm distal to the anastomosis was ligated with 10# suture.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date August 31, 2022
Est. primary completion date August 31, 2022
Accepts healthy volunteers No
Gender All
Age group 16 Years to 65 Years
Eligibility Inclusion Criteria:

- BMI = 32.5 kg/m2 with or without T2DM;

- 27.5 kg/ m2 < BMI < 32.5 kg/m2 with T2DM but failed conservative treatment and combined with at least two metabolic diseases or comorbidities;

- Duration of T2DM =15 years with fasting Cpeptide = 50% of normal lower limit

- Waist circumference: male = 90 cm, female = 85 cm

- Age within 16~65 years old

Exclusion Criteria:

- Pregnancy;

- A history of mental illness and neurological disease;

- The patient refuses surgery;

- Combined with pituitary tumor;

- Long-term use of antidepressant drugs;

- Long-term use of immunosuppressants;

- Situations in which the investigator or other examiner considers from the enrolled study that there are good reasons for nonconformity: if there are potential inconsistencies with the clinical protocol

Study Design


Intervention

Procedure:
SG-JJB
Base on SG-JJB procedure, the jejunum was not transected, only 200-cm jejunum 20-cm distal to Treiz ligament was measured and side-to-side jejunojejunal anastomosis was made. And the jejunum 3-5cm distal to the anastomosis was ligated with 10# suture.

Locations

Country Name City State
China Beijing Chaoyang Hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Zhen Jun Wang

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary excessive weight loss Percentage of excess weight loss (EWL) at any time postoperative was calculated as the amount of weight loss divided by the amount of excess weight times 100%. 1 year postoperatively
Primary total weight loss total weight loss compared with preoperative weight 1 year postoperatively
Secondary Complications Complications within 30 days postoperatively 30 days postoperatively
Secondary operating time time from opeing of the operation to the end of the operation during the operation
Secondary intraoperative blood loss blood loss during the operation during the operation
See also
  Status Clinical Trial Phase
Terminated NCT03527810 - Hiatal Interrogation in Sleeve Gastrectomy N/A
Recruiting NCT06157606 - Prediction Model for Inadequate Weight Loss After Sleeve Gastrectomy
Completed NCT04082923 - Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric Surgery N/A
Recruiting NCT05856617 - Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients Phase 4
Withdrawn NCT03376399 - Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
Completed NCT03440138 - Defining Benchmarks in Bariatric Surgery
Recruiting NCT05620641 - Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy Phase 3
Enrolling by invitation NCT04168060 - Crural Dissection in Sleeve Gastrectomy N/A
Completed NCT03325764 - Fitness, Physical Activity and Movement Analysis in Obese Patients Undergoing Bariatric Surgery N/A
Recruiting NCT03467906 - Role of Dietary Habits in Efficacy of Bariatric Surgery - Study B
Recruiting NCT04237311 - Bariatric Surgery and Male Reproductive Function
Completed NCT03331536 - Skeletal Health in Bariatric Surgery Patients
Not yet recruiting NCT03070457 - Safety of an Early Discharge Protocol After Sleeve Gastrectomy N/A
Recruiting NCT05224791 - A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy
Recruiting NCT05452980 - Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients N/A
Recruiting NCT02823665 - The Effects of Bariatric Surgeries on Glucose Metabolism Early Phase 1
Recruiting NCT02210975 - An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients After Sleeve Gastrectomy N/A
Recruiting NCT05977790 - Determinant of Fetal Growth Retardation After Sleeve Gastrectomy: Involvement of Ghrelin
Recruiting NCT03776669 - Laparoscopic Sleeve Gastrectomy With or Without Hiatal Hernia Repair in Morbidly Obese Patients N/A
Recruiting NCT03891056 - Metabolic Surgery; Gastric Bypass vs Sleeve Gastrectomy; Efects Over Type 2 DM With Bad Metabolic Control (MSO1CT) N/A